🔎 Trials Near Me

Home › Mga Sakit sa Atay › Arizona

Pag-aaral pangklinika para sa Mga Sakit sa Atay sa Arizona

5 pag-aaral para sa Mga Sakit sa Atay ang naghahanap ng mga kalahok sa mga site sa Arizona.

Mga Lungsod sa Arizona

Opisyal na teksto ng pag-aaral (English)

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Arizona Liver Health, Chandler
  • Arizona Liver Health - Peoria, Peoria
  • Adobe Clinical Research, LLC, Tucson
  • at 1 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chandler
  • 89bio Clinical Study Site, Glendale
  • 89bio Clinical Study Site, Sun City
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Chandler
  • 89bio Clinical Study Site, Peoria
  • 89bio Clinical Study Site, Phoenix
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06419374

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  • Clinical Trial Site, Phoenix
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06600321

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

  • Arizona Clinical Trials - the Institute For Liver Health, Chandler
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT07559474

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.